{"nct_id":"NCT04795427","title":"Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2021-12-06","start_date_type":"ACTUAL","primary_completion_date":"2023-05-29","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}